Skip to content

Proton Radiation Therapy for Pituitary Adenoma

Clinical Outcomes Study of Proton Radiation Therapy for Pituitary Adenoma

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00798057
Acronym
PI01
Enrollment
16
Registered
2008-11-25
Start date
2007-10-31
Completion date
2015-07-31
Last updated
2015-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Adenoma

Keywords

Pituitary tumor, Outcomes, Proton radiation

Brief summary

The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on pituitary tumors and analyze possible side effects.

Detailed description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.

Interventions

None listed

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Histologically proven pituitary adenoma. * Age 18 years or older. * Status post biopsy, gross total resection (from initial surgery for recurrent disease) or subtotal resection. * Good to moderate neurological function status

Exclusion criteria

\*Previous radiation that would compromise the ability to deliver the prescribed treatment.

Design outcomes

Primary

MeasureTime frame
Collect and analyze outcome data on tumor control.When each patient has been followed for a minimum or 12 months and then again after 24 months to a maximum of 10 years.

Secondary

MeasureTime frame
Collect and analyze outcome data on normal tissue morbidity.When each patient has been followed for a minimum of 12 months and then again after 24 months to a maximum of 10 years.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026